Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
73.99 USD | +0.72% | +15.65% | -4.80% |
02:35pm | RBC Capital Adjusts Price Target on Bio-Techne to $72 From $71, Sector Perform Rating Kept | MT |
02:22pm | Baird Adjusts Bio-Techne Price Target to $81 From $73 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.80% | 11.55B | |
+12.08% | 42.68B | |
+0.67% | 42.4B | |
+46.62% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Bio-Techne Files Drug Master File With US FDA for ExCellerate GMP for Stem Cell Therapy